Respiri Limited (AU:RSH) has released an update.
Respiri Limited has successfully raised A$1.6 million through a strategic placement, welcoming Merchant Biotech Fund and Hamma Capital among other investors to its registry. This capital boost, complemented by recent strategic agreements and operational successes, positions the eHealth company for accelerated revenue growth and a confident stride towards profitability in the US market. The investment, at a 4% premium over the 10-day VWAP, underscores investor confidence in Respiri’s US strategy and its innovative remote patient monitoring solutions.
For further insights into AU:RSH stock, check out TipRanks’ Stock Analysis page.
